Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 receptor agonists are approved primarily for type 2 diabetes and, in some formulations, for weight management
tirzepatide side effects Because both medications act on GLP-1 receptors, they share a similar side effect profile
Who It's For (Based on Trial Inclusion Criteria) BMI 30 (obesity) OR BMI 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, high cholesterol, sleep apnea) Adults ages 1875 (some trials include narrower age ranges) People who have tried lifestyle interventions (diet and exercise) without sufficient weight loss Those with type 2 diabetes seeking both glucose control and weight loss People with obesity-related conditions that would improve with major weight reduction Who Should Avoid Retatrutide Based on trial exclusion criteria and the drug's mechanism, retatrutide is likely not appropriate for: Pregnancy or breastfeeding: Not studied in these populations
Direct Provider Care Work directly with Josh Peterson, FNP-C
Until federal law changes, ACA marketplace plans including Ambetter will continue to exclude weight-loss medications
